Severe thrombocytopenia and microangiopathic hemolytic anemia in pregnancy: A guide for the consulting hematologist. Am J Hematol 2021 Dec 01;96(12):1655-1665
Date
08/24/2021Pubmed ID
34424560Pubmed Central ID
PMC8616841DOI
10.1002/ajh.26328Scopus ID
2-s2.0-85114193939 (requires institutional sign-in at Scopus site) 26 CitationsAbstract
A hematologist receives a call from a maternal-fetal medicine (MFM) physician about a previously healthy patient who became ill at 25 weeks' gestation. Her mental status is deteriorating. There are signs of fetal distress. Platelet count and hemoglobin are falling. The MFM physician is considering the hemolysis, elevated liver enzymes and low platelet count (HELLP) syndrome. For the hematologist, everything seems unfamiliar. Our goal is to provide hematologists with the fundamental knowledge required for understanding and managing these patients who become suddenly and seriously ill during pregnancy and in whom thrombocytopenia and microangiopathic hemolytic anemia are part of their presentation.
Author List
Perez Botero J, Reese JA, George JN, McIntosh JJAuthor
Jennifer Jury Mcintosh DO Associate Professor in the Obstetrics and Gynecology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Anemia, HemolyticDisease Management
Female
Humans
Practice Guidelines as Topic
Pregnancy
Pregnancy Complications, Hematologic
Thrombocytopenia
